Angiotensin AT1 receptor inhibition: Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis

Circulation

Volumn 95, Issue 6, 1997, Pages 1592-1600

  Weinberg, Ellen O ^a,b   Lee, Min Ae ^d   Weigner, Marilyn ^a,b   Lindpaintner, Klaus ^d   Bishop, Sanford P ^c   Benedict, Claude R ^e   Ho, Kalon K L ^a,b   Douglas, Pamela S ^a,b   Chafizadeh, Edward ^a,b   Lorell, Beverly H ^a,b,f  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c University of Alabama at Birmingham   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

angiotensin; hypertrophy; receptors; stenosis, aortic

Indexed keywords

AMLODIPINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE; IRBESARTAN; MESSENGER RNA; ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT; BIPHENYL DERIVATIVE; NORADRENALIN; RENIN; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA STENOSIS; ARTICLE; ASCENDING AORTA; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INACTIVATION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HYPERTENSION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; ANIMAL; AORTA; AORTA VALVE STENOSIS; BLOOD; DRUG ANTAGONISM; ECHOCARDIOGRAPHY; HEART MUSCLE; HEART VENTRICLE FUNCTION; METABOLISM; PATHOLOGY;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA; AORTIC VALVE STENOSIS; BIPHENYL COMPOUNDS; ECHOCARDIOGRAPHY; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MYOCARDIUM; NOREPINEPHRINE; PEPTIDYL-DIPEPTIDASE A; RATS; RECEPTORS, ANGIOTENSIN; RENIN; TETRAZOLES; VENTRICULAR FUNCTION;

EID: 0031576873     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.6.1592     Document Type: Article

References (10)

1. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Study Group. N Engl J Med. 1987; 316:1429-1435.
2. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685-691.
3. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, on behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival And Ventricular Enlargement trial. N Engl J Med. 1992;327:669-677.
4. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res. 1985;57:84-95.
5. Richer C, Mulder P, Fornes P, Domergue V, Heudes D, Guidicelli J-F. Long-term treatment with trandolapril opposed cardiac remodeling and prolongs survival after myocardial infarction in rats. J Cardiovasc Pharmacol. 1992;20:147-156.
6. Sen S, Tarazi RC, Bumps FM. Reversal of cardiac hypertrophy in renal hypertensive rats: medical vs. surgical therapy. Am J Physiol. 1981;240:H408-H412.
7. Kromer EP, Riegger GAJ. Effects of long-term angiotensin converting enzyme inhibition of myocardial hypertrophy in experimental aortic stenosis in rats. Am J Cardiol. 1988;62:161-163.
8. Kromer EP, Elsner D, Riegger GAJ. Role of neurohumoral systems for pressure induced left ventricular hypertrophy in experimental supravalvular aortic stenosis in rats. Am J Hypertens. 1991; 4:521-524.
9. Baker KM, Chernin MI, Wixson SK, Aceto JF. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol. 1990;259:H324-H332.
10. Nakashima Y, Fouad FM, Tarazi RC. Regression of left ventricular hypertrophy from systemic hypertension by enalapril. Am J Cardiol. 1984;53:1044-1049.